These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31562114)

  • 1. Multilevel Features for Sensor-Based Assessment of Motor Fluctuation in Parkinson's Disease Subjects.
    Ghoraani B; Hssayeni MD; Bruack MM; Jimenez-Shahed J
    IEEE J Biomed Health Inform; 2020 May; 24(5):1284-1295. PubMed ID: 31562114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of response to medication in individuals with Parkinson's disease.
    Hssayeni MD; Burack MA; Jimenez-Shahed J; Ghoraani B
    Med Eng Phys; 2019 May; 67():33-43. PubMed ID: 30876817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Feature Extraction for Detection of Degree of Motor Fluctuation Severity in Parkinson's Disease Patients.
    Hssayeni MD; Jimenez-Shahed J; Ghoraani B
    Entropy (Basel); 2019 Feb; 21(2):. PubMed ID: 33266853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity.
    Roy SH; Cole BT; Gilmore LD; De Luca CJ; Thomas CA; Saint-Hilaire MM; Nawab SH
    Mov Disord; 2013 Jul; 28(8):1080-7. PubMed ID: 23520058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States.
    Thomas I; Westin J; Alam M; Bergquist F; Nyholm D; Senek M; Memedi M
    IEEE J Biomed Health Inform; 2018 Sep; 22(5):1341-1349. PubMed ID: 29989996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low-cost vision system based on the analysis of motor features for recognition and severity rating of Parkinson's Disease.
    Buongiorno D; Bortone I; Cascarano GD; Trotta GF; Brunetti A; Bevilacqua V
    BMC Med Inform Decis Mak; 2019 Dec; 19(Suppl 9):243. PubMed ID: 31830986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of spirography features for objective assessment of motor function in Parkinson's disease.
    Sadikov A; Groznik V; Možina M; Žabkar J; Nyholm D; Memedi M; Bratko I; Georgiev D
    Artif Intell Med; 2017 Sep; 81():54-62. PubMed ID: 28416144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic assessment of medication states of patients with Parkinson's disease using wearable sensors.
    Hssayeni MD; Burack MA; Ghoraani B
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():6082-6085. PubMed ID: 28269640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Motor Fluctuations in Parkinson's Disease Patients Based on a Single Inertial Sensor.
    Pérez-López C; Samà A; Rodríguez-Martín D; Català A; Cabestany J; Moreno-Arostegui JM; de Mingo E; Rodríguez-Molinero A
    Sensors (Basel); 2016 Dec; 16(12):. PubMed ID: 27983675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Dynamic Naturalistic Monitoring of Bradykinesia in Parkinson's Disease Using a Wrist-Worn Accelerometer.
    Habets JGV; Herff C; Kubben PL; Kuijf ML; Temel Y; Evers LJW; Bloem BR; Starr PA; Gilron R; Little S
    Sensors (Basel); 2021 Nov; 21(23):. PubMed ID: 34883886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait initiation is impaired in subjects with Parkinson's disease in the OFF state: Evidence from the analysis of the anticipatory postural adjustments through wearable inertial sensors.
    Bonora G; Mancini M; Carpinella I; Chiari L; Horak FB; Ferrarin M
    Gait Posture; 2017 Jan; 51():218-221. PubMed ID: 27816900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of real life eating difficulties in Parkinson's disease patients by measuring plate to mouth movement elongation with inertial sensors.
    Kyritsis K; Fagerberg P; Ioakimidis I; Chaudhuri KR; Reichmann H; Klingelhoefer L; Delopoulos A
    Sci Rep; 2021 Jan; 11(1):1632. PubMed ID: 33452324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support vector machine classification of Parkinson's disease and essential tremor subjects based on temporal fluctuation.
    Surangsrirat D; Thanawattano C; Pongthornseri R; Dumnin S; Anan C; Bhidayasiri R
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():6389-6392. PubMed ID: 28269710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiple motion sensors index for motor state quantification in Parkinson's disease.
    Aghanavesi S; Westin J; Bergquist F; Nyholm D; Askmark H; Aquilonius SM; Constantinescu R; Medvedev A; Spira J; Ohlsson F; Thomas I; Ericsson A; Buvarp DJ; Memedi M
    Comput Methods Programs Biomed; 2020 Jun; 189():105309. PubMed ID: 31982667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Learning for Medication Assessment of Individuals with Parkinson's Disease Using Wearable Sensors.
    Hssayeni MD; Adams JL; Ghoraani B
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():1-4. PubMed ID: 30440318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct alterations in Parkinson's medication-state and disease-state connectivity.
    Ng B; Varoquaux G; Poline JB; Thirion B; Greicius MD; Poston KL
    Neuroimage Clin; 2017; 16():575-585. PubMed ID: 28971008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease detection from 20-step walking tests using inertial sensors of a smartphone: Machine learning approach based on an observational case-control study.
    Juutinen M; Wang C; Zhu J; Haladjian J; Ruokolainen J; Puustinen J; Vehkaoja A
    PLoS One; 2020; 15(7):e0236258. PubMed ID: 32701955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.
    Di Lazzaro G; Ricci M; Al-Wardat M; Schirinzi T; Scalise S; Giannini F; Mercuri NB; Saggio G; Pisani A
    J Parkinsons Dis; 2020; 10(1):113-122. PubMed ID: 31594252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.